Statins decreases expression of five inflammation-associated microRNAs in the plasma of patients with unstable angina
10.3969/j.issn.1671-167X.2015.05.006
- VernacularTitle:他汀类药物可降低不稳定性心绞痛患者血浆中炎症相关 microRNAs 的表达水平
- Author:
Jing ZHANG
;
Jingyi REN
;
Hong CHEN
;
Guanping HAN
- Publication Type:Journal Article
- Keywords:
Angina,unstable;
MicroRNAs;
Statins;
Plasma
- From:
Journal of Peking University(Health Sciences)
2015;(5):761-768
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the influence of treatment with HMG-CoA reductase inhibitors ( sta-tins) on the expression profile of microRNAs ( miRNAs) in the plasma of patients with unstable angina ( UA) .Methods:The Taqman low-density miRNA array ( TLDA) and significance analysis of microar-rays ( SAM) were used to identify distinct miRNA expression profiles in the plasma of UA patients treated with long-term and regular statins ( UA receiving statins , n=6 ) compared with UA patients who had not received statins therapy before ( UA received no statins , n=6 ) .These differentially expressed miRNAs discovered in the profiling were further validated by real-time PCR in another 20 controls with non-cardiac chest pain , 26 UA patients received no statins , and 19 UA patients received statins .Results: By using TLDA and SAM , significantly decreased expression levels of 21 miRNAs were observed in the UA pa-tients receiving statins compared with those who received no statins ( fold change >3 and false discovery rate<0 .0001%) .The unsupervised hierarchical clustering based on miRNA expression clearly separa-ted the UA patients receiving statins from those who received no statins .Consistent with the profiling da-ta, the levels of 5 inflammation-associated miRNAs (miR-106b, miR-21, miR-25, miR-451, and miR-92a) were down regulated (P<0.05) in the UA patients receiving statins compared with those who re-ceived no statins.Conclusion: A group of inflammation-associated miRNAs, consisting of miR-106b, miR-21, miR-25, miR-451, and miR-92a, could be decreased by treatment with statins and may be used as a novel biomarker for effectiveness of statins therapy in patients with UA .
